logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Portola Pharmaceuticals, Inc.


USPTO Granted Patents = 71

% Expired Patents = 18.3



Trademarks = 4

Forward Citations = 470

Loading Chart...
Loading Chart...

64 inventors (with patents filed for the assignee):

goldMedal Anjali Pandey (35 out of 83 patents)

silverMedal Yonghong Song (26 out of 61 patents)

bronzeMedal Shawn M Bauer (24 out of 30 patents)

4.  Qing Xu (22 out of 54 patents)

5.  Wolin Huang (22 out of 26 patents)

6.  Zhaozhong Jon Jia (18 out of 41 patents)

7.  Robert M Scarborough (16 out of 153 patents)

8.  Mukund Mehrotra (14 out of 20 patents)

9.  Jack W Rose (14 out of 15 patents)

10.  Uma Sinha (14 out of 32 patents)

11.  Genmin Lu (14 out of 20 patents)

12.  Patrick Andre (11 out of 18 patents)

13.  Brian Kane (11 out of 18 patents)

14.  David R Phillips (10 out of 28 patents)

15.  Charles K Marlowe (9 out of 22 patents)


Core Competencies:
Cerdulatinib
Factor Xa Inhibitors
Syk Modulators
JAK Inhibitors
Protein Kinases
Antidotes
Pharmaceutical Compositions
Purification Methods
Unit Dose Formulations
Combination Therapy
Crystalline Forms
Platelet ADP Receptor Inhibitors

71 patents:

1. 12685763 - METHODS FOR TREATING INTRACRANIAL HEMORRHAGE AND ASSESSING EFFICACY (2026-07-21),
2. 10851087 - Synthesis of cerdulatinib (2020-12-01),
3. 10765726 - Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the same (2020-09-08),
4. 10736895 - Cerdulatinib for treating hematological cancers (2020-08-11),
5. 10675335 - Antidotes for factor Xa inhibitors and methods of using the same (2020-06-09),
6. 10604748 - Preparation of factor Xa derivatives (2020-03-31),
7. 10533001 - Inhibitors of protein kinases (2020-01-14),
8. 10190111 - Antidotes for factor Xa inhibitors and methods of using the same (2019-01-29),
9. 9902688 - Benzamides and nicotinamides as Syk modulators (2018-02-27),
10. 9868729 - Inhibitors of protein kinases (2018-01-16),
11. 9834548 - Pyridazine compounds as JAK inhibitors (2017-12-05),
12. 9676756 - Substituted pyrimidinyl kinase inhibitors (2017-06-13),
13. 9644195 - Compounds and methods for purification of serine proteases (2017-05-09),
14. 9587233 - Antidotes for factor XA inhibitors and methods of using the same (2017-03-07),
15. 9579320 - Inhibitors of syk and JAK protein kinases (2017-02-28),
Portola Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics in the areas of thrombosis, platelet disorders, and hematology. They strive to provide innovative treatment options for patients with unmet medical needs. Visit their website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 8 2026

Portola Pharmaceuticals, Inc.
71 Patents

#21 in South San Francisco, CA

#1,211 in California

#5,153 in US

#10,471 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Portola Pharmaceuticals, Inc.

Forward Citations = 470

64 inventors:

goldMedal Anjali Pandey (35 out of 83 patents)

silverMedal Yonghong Song (26 out of 61 patents)

bronzeMedal Shawn M Bauer (24 out of 30 patents)

4.  Qing Xu (22 out of 54 patents)

5.  Wolin Huang (22 out of 26 patents)

Please report any incorrect information to [email protected]
Loading…